To identify genes potentially implicated in atherogenesis, a cDNA library was constructed from human atherosclerotic aorta and differentially screened with 32 P-labeled-cDNAs prepared from human normal and atherosclerotic aortas. Two cDNA clones exhibiting higher hybridization to the 32 P-labeled cDNAs from atherosclerotic vessels were isolated and identified to be genes encoding L-ferritin and H-ferritin, respectively. Northern blot analysis confirmed that the expression of both ferritin genes was notably higher in human and rabbit atherosclerotic aortas than in their normal counterparts. A time-course study illustrated that both L-and H-ferritin mRNAs were markedly increased in aortas of rabbits after feeding with a high cholesterol diet for 6 wk, which was also the time period after which the formation of lesions became evident. In situ hybridization re- 
Introduction
Atherosclerosis is a pathological process which eventually leads to the obstruction of blood vessels. The development of atherosclerotic lesions is believed to be initiated by injury of the endothelium, followed by activation and infiltration of monocytes and T-lymphocytes, and differentiation of monocytes into macrophages in the subendothelium (1, 2) . Subsequently, plaques are formed, and these are characterized by the accumulation of lipid droplets in foam cells derived from macrophages and smooth muscle cells, the proliferation of smooth muscle cells, and the accumulation of matrix proteins in the extracellular spaces, which leads to the thickening of the intima (1, 2) . Activation of the vascular endothelial cells and smooth muscle cells as well as other inflammatory cell components appears to be essential to the initiation and progression of plaque formation. Alteration in expression of genes encoding growth factors (3) (4) (5) (6) , receptors (5) (6) (7) (8) , adhesion molecules (9-11), cytokines (3, 4) , chemoattractants (12, 13 ) and matrix-associated proteins (14) (15) (16) has been shown to be implicated in atherogenesis. Due to the disease's complex and multifactorial nature, many genes which are not presently uncovered may also play important roles in the course of plaque formation. In an attempt to identify such atherosclerosis-associated genes, we have constructed a cDNA library from human atherosclerotic aorta. Differential screening of this library with cDNAs prepared from poly(A ϩ )RNAs of human normal and atherosclerotic aortas has allowed us to isolate cDNA clones which are highly expressed in the disease state. Here we report the identification of two cDNA clones which encode the iron-binding proteins, L-ferritin and H-ferritin (17) , from the differential screening. Northern blot analysis and in situ hybridization demonstrated that these two genes are highly induced in atherosclerotic lesions of humans and rabbits. Since alterations in ferritin expression would obviously affect the intracellular iron availability which in turn has a great impact on many metabolic processes in cells, the present finding implies that these cellular iron-binding proteins play a role in the progression of the disease.
Methods
Human tissue samples. Samples of human atherosclerotic aortas were obtained during surgery from patients ( n ϭ 6) with abdominal aneurysm. Normal aortas and aortas with early fatty streaks were obtained from organ donors ( n ϭ 2) for heart transplantation or from patients ( n ϭ 4) during bypass surgery. Tissue samples were immediately rinsed with ice-cold saline solution and immediately frozen in liquid nitrogen for RNA isolation or immersion-fixed with 4% paraformaldehyde then paraffin-embedded for hematoxylin-eosin staining or other experiments. For cDNA library construction, the poly(A ϩ ) RNA isolated from an abdominal aortic aneurysm was used. The tissue sections prepared from three ascending aortas (early lesions) and four abdominal aortas (advanced fibrous lesions) were examined and used for in situ hybridization, immunocytochemistry, and iron-histochemistry.
Experimental animals. New Zealand White male rabbits (2 kg body wt) were fed with either regular feed, regular feed supplemented with 6% corn oil, or regular feed supplemented with 6% corn oil and 2% cholesterol for 1-6 wk. Each group consisted of four age-matched animals. Animals were anesthetized with i.v. injection of 35-40 mg/kg sodium pentobarbital. Aortas were removed, rinsed with ice-cold sa-line, and immediately frozen for RNA isolation or fixed with paraformaldehyde as described above.
RNA isolation and library construction. Total RNA of aortas were isolated as described by Chomczynski and Sacchi (18). For isolation of poly(A ϩ )RNA, the total RNA was applied onto an oligo(dT)-cellulose column and poly(A ϩ )RNA was eluted (19) . Synthesis of the first and second strands of cDNA was carried out using a cDNA synthesis kit following the protocol provided by the manufacturer (Bethesda Research Laboratories, Gaithersburg, MD). To construct the human atherosclerotic aorta cDNA library, the blunt-ended cDNA prepared from the human atherosclerotic aorta was ligated with EcoRI adaptor followed by cloning into the lambda gt11 arms. The ligated recombinant lambda phages were packaged and transfected into the host cell Y1090. Before screening, the library was amplified once and stored in the presence of 7% DMSO at Ϫ 70 Њ C.
Differential screening of the cDNA library. For differential screening, aliquots of the human atherosclerotic aorta cDNA library were plated out on 100-mm plates at a density of 500-600 pfu per plate. Bacteriophage infection and plating of infected Escherichia coli onto plates were carried out accordingly (20) . The plates were incubated at 37 Њ C until plaques were visible. Colonies were transferred onto nylon filters and lysed. Filters were first hybridized to 32 P-labeled cDNA synthesized from normal human aorta mRNA as described above and labeled with [ ␣ -32 P]dCTP by random priming (Amersham Corp., Little Chalfont, England) under conditions as described in "Northern blot analysis." After autoradiography, probes on the filters were stripped off by boiling in 0.1% SDS for 5 min. Filters were immediately hybridized to 32 P-labeled cDNA synthesized from human atherosclerotic aorta mRNA. Colonies which showed stronger signals (greater than fivefold) from hybridization with the atherosclerotic lesion probes were further analyzed.
DNA sequencing. The cDNA insert of the isolated phage clone was amplified with a pair of lambda gt11 primers flanking the EcoRI cloning site. An aliquot from the phage lysate was denatured at 95 Њ C for 5 min and then subjected to PCR with Taq polymerase. The PCR was performed by 40 cycles of denaturation at 94 Њ C for 1 min, annealing at 55 Њ C for 1 min, and extension at 72 Њ C for 2 min. Amplified cDNA was electrophoresed on a 1% agarose gel and excised from the gel. The cDNA was then extracted and purified from the gel by DNA purification kit from Qiagen Inc. (Hilden, Germany). DNA sequencing was performed on ABI 373A automated DNA sequencer by dyedeoxy terminator cycle sequencing methods according to the manufacturer's instructions. Sequence analysis was conducted using the GenBank Database in National Center for Biotechnology Information, NIH, Bethesda, MD.
Northern blot analysis. Equal amounts (5-10 g) of total RNA were denatured and electrophoresed on 1% agarose gel containing 6.6% formaldehyde for 2 h at 120 V. After electrophoresis, RNA was transferred onto nylon membrane and fixed by ultraviolet irradiation. Membranes were prehybridized for at least 1 h at 42 Њ C in prehybridization solution containing 10% dextran sulfate, 1% SDS, 50% formamide, 1 M NaCl, and 1 mg/ml denatured sonicated salmon sperm DNA. 32 P-labeled cDNA probes at 10 6 cpm/ml were added and the hybridization was continued at 42 Њ C overnight. Blots were then washed with buffer containing 2 ϫ SSC (1 ϫ SSC consisted of 150 mM NaCl, 15 mM Na-citrate, pH 7.0) and 1% SDS for 30 min at 50 Њ C, followed by wash with buffer containing 0.2 ϫ SSC and 1% SDS for another 30 min at 50 Њ C. The blot was covered in Saran wrap to prevent drying and exposed to Kodak XAR-5 film at Ϫ 70 Њ C using Kodak intensifying screen.
In-situ hybridization. L-ferritin and H-ferritin cDNAs, which contain entire coding sequences, were subcloned into pcDNA3 vector, respectively. The antisense RNA was then prepared by SP6 RNA polymerase and labeled with digoxigenin(DIG) 1 -UTP according to manufacturer's instructions (Boehringer Mannheim Biochemica, Mannheim, Germany) and used as probes for in situ hybridization, which was performed according to a published method (21) . Paraffinembedded tissue sections (5-6-m thick) were placed on poly-l -lysinecoated slides, deparaffinized, treated with proteinase K (1 g/ml for 15 min at 37 Њ C) and acetylated (0.25% acetic anhydride in 0.1 M triethanolamine and 0.9% NaCl for 10 min). Sections were then washed with 2 ϫ SSC, dehydrated, and air dried for 30 min. Before hybridization, each section was prehybridized in a humid chamber with 100 l prehybridization solution containing 5 ϫ SSC, 5 ϫ Denhardt's solution, 50% deionized formamide, 250 g/ml yeast t-RNA, 250 g denatured salmon sperm DNA, and 4 mM EDTA for 3 h at 50 Њ C. Hybridization was performed at 50 Њ C for 16-24 h in a humid chamber with 25 l/section prehybridization solution containing 10 ng/ l RNA probe. After the hybridization, sections were washed at 42 Њ C twice in 2 ϫ SSC, once in 0.2 ϫ SSC and 0.1 ϫ SSC for 15 min per wash. Sections were then blocked (30 min), incubated with alkaline phosphatase-conjugated anti-DIG antibody (30 min), and detected with color solution containing 337.5 g/ml nitroblue tetrazolium salt/175 g/ml 5-bromo-4-chloro-3-indolyl-phosphate (10-30 min) according to the manufacturer's instructions (DIG labeling and detection kit; Boehringer Mannheim Biochemica). After completion of the color reaction, each section was counterstained with carmin. In some experiments, tissue sections were hybridized with DIG-labeled sense-RNA probes, which resulted in no detectable signals.
Iron histochemistry. Iron deposits on atherosclerotic lesions were examined by Perls' Prussian blue reaction with 3,3'-diaminobenzidine (DAB) intensification (22) . Briefly, after Perls' reaction, section was incubated with 0.5% DAB in 0.1 M phosphate buffer, pH 7.4, for 20 min, followed by 15 min in the same medium containing 0.005% H 2 O 2 . The reaction was stopped by rinsing in deionized H 2 O for Ͼ 30 min and then counterstained with carmin. Negative control slide was carried out through the DAB intensification without preincubation with Perl's solution. No positive staining was detected in the negative control sections.
Immunohistochemistry. Immunostaining was carried out using the following antibodies purchased from DAKO Japan Co. Ltd. (Kyoto, Japan): rabbit polyclonal antibody against human ferritin; mouse mAb against smooth muscle cell ␣ -actin; mouse mAb against human macrophage CD68; and mouse mAb against human vWf. Tissue sections were deparaffinized, rehydrated, and blocked in PBS containing 1% BSA and 1% goat serum at room temperature for 30 min. Incubation with primary antibody or secondary FITC-conjugated goat anti-mouse or anti-rabbit antibody (Sigma Chemical Co., St. Louis, MO) was performed at room temperature for 30 min followed by three 5-min washes in PBS. Negative control was performed by incubating the tissue sections with secondary antibody without pretreatment with primary antibody.
Regulation of ferritin gene expression in cultured cells. A human aorta-vascular smooth muscle cells cell line (with passage number of 11) was obtained from American Type Culture Collection (CRL-1999; Rockville, MD). Cells were grown in formulated SmGM™ medium supplemented with 5% FBS (Clonetics, San Diego, CA) at 37 Њ C in a CO 2 incubator (95% air/5% CO 2 ). After reaching confluency, cells were deprived of serum in DMEM medium for 2 d before experiments. Human monocytic THP-1 cells were grown in RPMI 1640 medium supplemented with 10% FBS. Cells were harvested at a density of 10 6 /ml and used for experiments. Oxidized LDL were prepared accordingly (23) with some modification. Briefly, human LDL was isolated from plasma by sequential ultracentrifugation and desalted by Sephedex G-50 gel filtration. LDL (0.5 mg/ml) was incubated with 5 M CuSO 4 at 37 Њ C in PBS for 3 h. (Sigma Chemical Co.) using E. coli 055:B5 lipopolysaccharide as a standard. Less than 0.01 endotoxin U could be detected in 100 g of LDL protein. Various cytokines or oxidized LDL were added into the culture and the incubation was continued for 24 h. Total RNAs were isolated, and Northern blots were performed as described above.
Results
Differential screening of a human atherosclerotic cDNA library. A cDNA library in phage lambda gt11 was constructed from a human abdominal aortic aneurysm. Histological examination of the aneurysm tissue revealed that it contained advanced atherosclerotic lesion associated with some degree of local chronic inflammation, which was characterized by the presence of T lymphocytes, plasma cells, and macrophages in the adventitia (24) . This library presumably contains genes which are highly expressed in the disease state, including those associated with atherosclerosis. Differential screening of this library with 32 P-labeled cDNAs from human normal and atherosclerotic aortas allowed us to identify the clones that are highly expressed in the atherosclerotic lesions. Phage clones which exhibited stronger hybridization signals with the 32 P-labeled cDNA probes prepared from atherosclerotic vessels were picked up. After the second round of hybridization to confirm the differential signals, the cDNA inserts of the isolated clones were amplified by PCR and subjected to DNA sequence analysis. The identity of the cDNA clones was then revealed by searching for any homology with the EMBL/GenBank data base. Five cDNA clones were isolated from the initial screening of 10,000 phage clones. Among them, two were novel genes. One clone was identified to be a gene encoding for the heavy chain of IgG, which was presumably derived from plasma cells. Furthermore, it was very interesting to find that the other two clones showed 99.0 and 96% homologies to the sequences of the genes encoding human L-ferritin and H-ferritin, respectively. The high expression of the ferritin genes in human atherosclerotic aortas was further confirmed by Northern blot analysis. As shown in Fig. 1 A , the expression of both L-ferritin and H-ferritin mRNAs was at least 10-fold higher in human atherosclerotic aorta than in normal aorta. Similarly, atherosclerotic aortic arch induced in rabbits by a high cholesterol diet also exhibited significantly higher expression of ferritin genes than the normal rabbit aorta control (Fig. 1 B ) .
To address the question of whether the induction of ferritin genes is correlated with the development of atherosclerotic lesions, a time course experiment was conducted to examine the expression levels of both ferritin genes in rabbits fed with a high cholesterol diet for various times. As shown in Fig. 2 A , plaque was clearly formed in the aorta of the animals only after 6 wk of feeding with a high cholesterol diet. Likewise, the expression of both L-and H-ferritin genes in the aorta did not significantly increase until 6 wk of high cholesterol diet (Fig. 2  B ) . This result clearly illustrates that the induction of ferritin expression parallels the progression of lesion formation. A similar time course was seen for the induction of monocyte chemoattractant protein-1 (MCP-1), which is one of several highly expressed genes detected in atherosclerotic plaques (12) (Fig. 2 B ) . Besides in the aortic arch, the increased expression of ferritin genes was also found in the abdominal aorta and thoracic aorta of cholesterol-fed rabbits (Fig. 3) , although the degrees of induction varied among different sections of aorta. Localization of the induced ferritin genes in lesions by in situ hybridization. To further examine the cellular localization of the induced ferritin genes, in situ hybridization with atherosclerotic lesions of human aortas was performed. As illustrated in Fig. 4 , both L-and H-ferritin mRNAs were shown to be present mainly on the thickened intima of the human fatty streak. Immunostaining of the serial sections with specific antibody to human macrophage demonstrated that the cells responsible for the expression of both ferritin genes are macrophages. Positive hybridization signals were also detected on a few of the endothelial cells as shown in the same figure.
There was no signal detected in the medial smooth muscle cells. In all of the three human early lesions examined, the expression of both ferritin mRNAs in macrophages was prominent. However, the signals in endothelial cells were detectable only in two of the lesions, indicating that macrophage is the major cell type for the induction of ferritin genes in early lesions. When the in situ hybridization was performed with human advanced atherosclerotic lesions, both L-and H-ferritin mRNA signals were detected in areas rich in smooth muscle cells as revealed by the immunoreactivity with specific antibody to ␣ -actin (Fig. 5) . The expression of ferritin mRNAs in smooth muscle cells was observed in all of the four advanced lesions examined. However, the hybridization signals in macrophages, which were found scattered along the lipid core of the advanced lesions, were markedly diminished (data not shown). This observation indicates that the ferritin gene induc- tion during the later stage of lesion progression occurs mainly in smooth muscle cells.
Iron histochemistry and ferritin immunocytochemistry. To elucidate the potential involvement of iron in the up-regulation of ferritin expression (25) , the presence of iron in atherosclerotic lesions was examined by Perls' reaction. As illustrated in Fig. 6 B , no positive staining was detected in the early lesion of rabbit aorta. Similarly, iron staining was not detected in human early fatty streak (Fig. 6 C ) , although immunostaining of the serial sections with specific antibody to human ferritin revealed strong immunoreactivity on the thickened intima (Fig.  6, D and E ) . In parallel with the gene expression revealed by in situ hybridization, the induced ferritin protein in early lesion was mainly detected in macrophages of the intima and some of the endothelial cells (Fig. 6 E ) . When Perls' reaction was performed with human advanced lesion, it was very interesting to observe that a strong positive reaction appeared in the area that colocalized with the strong ferritin immunoreactivity (Fig.  7) . These results imply that iron is not responsible for the induction of ferritin gene expression in the early course of plaque formation. Nevertheless, deposition of iron in lesion appeared to be subsequently augmented, which may be, in part, due to the increased ferritin in the late stage of atherosclerosis.
Regulation of ferritin gene expression in cultured human monocytic THP-1 cells and aortic smooth muscle cells.
The expression of ferritin genes is subjected to regulation by cytokines in a number of cell types, including adipocytes, myoblasts, and monocytes (26) (27) (28) (29) . To elucidate the possible mechanisms responsible for the elevated ferritin gene expression in atherosclerotic lesions, we examined the effects of cytokines, including IL-1, TNF, TGF, and PDGF on the mRNA levels of L-and H-ferritin in cultured human THP-1 and aortic smooth muscle cells. As shown in Fig. 8 A , treatment of THP-1 cells with TNF for 24 h significantly increased in mRNA levels of MCP-1 and both ferritins. On the other hand, IL-1, TGF, and PDGF exerted no effect on mRNAs of MCP-1 or ferritin genes under the same incubation conditions. The effect of oxidized LDL, which is present in the lesions and exerts atherogenic activity (30) on ferritin gene expression was also examined. Oxidized LDL increased MCP-1 expression but did not affect the expression of either ferritin gene (Fig. 8 A ) . The fact that oxidized LDL was ineffective at inducing ferritin gene expression was not due to the presence of the antioxidant, BHT, which was added during the preparation of oxidized LDL, in the culture medium, since BHT alone at the same concentration (0.8 M) or the dialyzed oxidized LDL preparation de- Increased ferritin gene expression in various sections of aortas of the rabbits fed with a high cholesterol diet for 6 wk. The total RNAs were isolated from indicated parts of the aortas, and Northern blot was performed as described in Methods. N, O, and C refer to the animal groups fed with regular diet, regular diet supplemented with 6% corn oil, and regular supplemented with 6% corn oil plus 2% cholesterol, respectively. void of BHT did not affect the levels of both ferritin mRNAs (data not shown). On the other hand, the expression of H-ferritin mRNA, but not L-ferritin mRNA, was induced by two to threefold after treatment with TNF or IL-1 in aortic smooth muscle cells (Fig. 8 B) . Again, TGF, PDGF, and oxidized LDL did not show any effect on the expression of either ferritin gene.
Discussion
By differentially screening a cDNA library of human atherosclerotic aorta, we have identified that genes for the iron-storage proteins, L-ferritin and H-ferritin, are highly expressed in human atherosclerotic vessels. A similar result was found in atherosclerotic aorta obtained from rabbits which were fed a high cholesterol diet. Time course study of aorta from the rabbits further revealed a close association between lesion formation and increased ferritin gene expression. As demonstrated in Fig. 2 , the induction of ferritin genes in the rabbits was not prominent until 6 wk after they had started eating a high fat diet, which paralleled the expression of the MCP-1 gene and formation of plaque characterized as early fatty streak. This observation suggests that the induction of ferritin genes occurs in the early phase of progression of lesions. Furthermore, it was interesting to notice that the degree of the ferritin gene expression in various parts of the aortas in the high cholesterol diet-fed rabbits (Fig. 3) was in parallel to the severity of the lesions found in the different areas (data not shown).
In mammalian cells, ferritin is known to exist as a high molecular mass complex composed of 24 subunits of H-and L-ferritin. H-and L-ferritins are derived from two distinct genes and show only ‫ف‬ 50% homology in primary amino acid sequences (17) . The H/L ferritin ratio varies widely in different tissues and cells. L-chain-rich ferritin predominates in ironstorage organs, such as liver and spleen; while H-chain-rich ferritin predominates in organs of low iron content, such as heart and pancreas. Since H-ferritin can bind and release iron more easily than L-ferritin, it is generally believed that H-ferritin plays a key role in intracellular iron transport, whereas L-ferritin is associated with iron storage (17) . As a whole, the main function of ferritin is the storage and delivery of iron for intracellular use. Alternatively, it functions as a chelator sequestering intracellular unbound iron, particularly ferrous iron which is toxic to cells by acting as a strong in vivo catalyst for oxidative free radical reaction (31) . The antioxidant role of ferritin was shown to be closely associated with the intrinsic ferroxidase activity, which converts ferrous iron to ferric iron, in H-ferritin (32) . Regulation of ferritin gene expression can occur at multiple levels. It is well documented that biosynthesis of ferritin is regulated by iron at the translational level (25) . When intracellular iron concentration is low, synthesis is repressed through the interaction between an iron-responsive element, which is located in the 5Ј-untranslated region of both L-and H-ferritin mRNAs, and a 90-kD repressor protein. Increased intracellular iron would lead to the release of the repressor protein and permit subsequent translation of the mRNAs. In some cell types, expression of L-ferritin gene has also been shown to be regulated by iron at the transcriptional level (33, 34) .
In addition to iron, increased ferritin gene expression was also observed in other circumstances, including cell differentiation, proliferation, inflammation, and specific hormonal signals (35) (36) (37) (38) . Recently, a number of studies have demonstrated an increase in ferritin synthesis after induction of heme oxygenase in different types of cultured cells, including endothelial cells, subjected to oxidative stress (32, (39) (40) (41) (42) . The increased iron pool derived from the degradation of heme by heme oxygenase was mainly responsible for the increased ferritin expression, primarily at a translational level. It was shown that the newly synthesized apoferritin acts as an antioxidant to protect cells from further insult through its iron-sequestration capability. In contrast to the cytoprotective role, other studies, however, have shown that ferritin is a source of active catalytic iron causing oxidative damage by the fact that superoxide radicals generated by stimulated cells would subsequently cause the release of iron from ferritin (43) . A recent study on an in vivo animal model has shown that liver ferritin can represent either a pro-or an antioxidant in a time-dependent manner in rats subjected to oxidative stress (42) . It appears that the functional role of ferritin in cells during oxidative insults is circumstantial. Currently, the oxidation of LDL in the subendothelial space is recognized as one of the early events in atherogenesis (30) . In vitro studies have shown that LDL is subjected to oxidative modification in culture by a range of cell types, including endothelial cells (44) , arterial smooth muscle cells (45) , as well as macrophages (46), and is subsequently taken up through the scavenger receptors by macrophages to become foam cells which are the pathological hallmark of early atherosclerotic lesions (1, 2) . It has been shown that small amounts of iron are an absolute requirement for oxidation of LDL by cultured cells, suggesting the involvement of iron in LDL oxidation. This notion is supported by a recent study by Smith et al. (47) , who showed that the interior of advanced human atherosclerotic lesions provides a highly pro-oxidant environment, containing iron and copper ions which are available to catalyze free radical reactions as well as lipid oxidation. Recently, studies on human subjects have shown that the serum ferritin concentration, which reflects the level of total body iron stores, was positively correlated with a high risk of cardiovascular disorders, such as acute myocardial infarction (48) and carotid atherosclerosis (49) . Although the physiological relevance of the increased level of serum ferritin in atherosclerosis remains to be clarified, the present study has provided strong evidence to support the implication of iron-storage proteins in the progression of the disease. Consistent with the present observation, a recent report by Juckett et al. has also demonstrated the presence of increased immunoreactive ferritin in human coronary atherosclerotic lesions, although no iron deposition was detected in their study (50) .
By both in situ hybridization and immunocytochemistry, the induced L-and H-ferritin genes were shown to be located mainly in macrophages and some of the endothelial cells of the thickened intima in the human early atherosclerotic lesion (Fig. 4) , while both signals were detected mainly in smooth muscle cells of advanced lesions (Fig. 5) . The increase in expression of ferritin protein in early lesion, as demonstrated by immunostaining, however, was not accompanied by the augmented iron deposition as examined by Perls' Prussian blue reaction (Fig. 6 ). This result suggests that iron, which is known to up-regulate ferritin biosynthesis at the transcriptional or posttranscriptional level (25) , is not the primary cause leading to the induction of ferritin gene expression in the atherosclerotic lesion. Conversely, the newly synthesized ferritins present in early lesion appeared to be apoproteins, which might serve as intracellular chelators for free iron to protect cells from further oxidative damage caused by iron overload or other stress conditions and limit the propagation of the tissue injury. However, when the plaque progressed to a more severe lesion, iron deposition became evident in areas rich in ferritins, indicating that the ferritins were subsequently laden with iron along with the progression of the lesion. Since the vascular damage would be augmented in the late stage of atherosclerosis, it is speculative that the presence of iron-bound ferritin at sites of damage in which increased superoxide formation occurs might in turn lead to increased oxidative insults. Apparently, the paradoxical roles of ferritin implicated in atherogenesis will largely depend upon the stage of the atherosclerotic lesion and the status of iron loading within ferritin macromolecules.
Previous studies in a number of cell systems have demonstrated that the expression of ferritin genes is up-regulated after stimulation by cytokines (26) (27) (28) (29) . Increased cytokine generation after the activation of monocytes and endothelial cells has been observed in the early phase of plaque formation (51) . To elucidate whether cytokines are responsible for inducing ferritin genes in atherosclerotic lesions, we cultured human (30) did not effectively alter ferritin gene expression under our experimental conditions. These results suggest that the expressions for L-ferritin and H-ferritin genes are subject to differential regulation in different cell types as the plaque progresses.
In summary, the present study clearly demonstrates the high expression of ferritin genes in atherosclerotic lesions. The induction is closely associated with the development of plaques. Although the physiological relevance of ferritin in atherogenesis is not yet fully understood, it is conceivable that increased expression of the iron-binding protein in atherosclerotic lesion would affect the progression of the disease. . Cultured cells were treated without (Control) or with IL-1 (25 ng/ml), TNF (10 ng/ml), TGF (5 ng/ ml), PDGF (2.5 ng/ml), or oxidized LDL (20 g/ml) for 24 h. Total RNAs were isolated and Northern blot analysis with indicated cDNA probe was performed.
